As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US ...

Cirius Therapeutics, Inc.,  developing innovative therapies for patients suffering from diseases caused by insulin resistance, including obesity/overweight and type 2 diabetes (T2D), today announced ...

Welldoc®, a leader in AI-powered digital health innovation, today announced it will power the newly launched Lilly Healthtm Personalized Health & Medicine Platform* (Lilly Health app) with its ...

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

Later, the FDA permitted the makers of Mounjaro (tirzepatide) to market it for ... removing the FDA's restrictions on compounding pharmacies can go a long way toward making GLP-1s less expensive.

U.K. regulators issued guidance on Thursday, warning weight loss and diabetes medications may weaken the effectiveness of ...